Back to search
Breast Carcinoma In Situ
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Carcinoma In Situ trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Breast Carcinoma In Situ trials you may qualify forThe goal of this trial is to see if active surveillance monitoring and hormonal therapy in patients diagnosed with ductal cell carcinoma in situ (DCIS), an earl…
This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast su…
This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Inc…
The standard surgical approach for all patients undergoing mastectomy for the treatment of non-invasive, ductal carcinoma in situ (DCIS) is to perform axillary…
This phase II trial tests the effectiveness of cannabidiol (CBD) plant extract (BRC-001) in improving joint stiffness and pain (arthralgia) in women with breast…
This phase III trial tests whether vaginal fractional CO2 laser therapy works in treating vaginal dryness in breast cancer survivors. Vaginal dryness can be com…
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with…
This study will evaluate the local control, complication rates, cosmetic results, and quality of life between patients treated with a single fraction vs. five f…